OptimizeRx Corporation

NASDAQ:OPRX

Medical - Healthcare Information Services

Healthcare
$7.31 -0.98%

-$0.05 today

Market cap
$138.21M
Beta
1.10
P/E (TTM)
13.8
EPS (TTM)
$0.36
52W Low $4.57High $22.25

Volume 0.18M

Average 0.47M

OPRX Account Payables

Amounts the company owes suppliers for goods and services received.

OptimizeRx CorporationNASDAQ: OPRX

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables falls 9.3% from a year ago

Account payables stood at $3.07M at the end of Q1 FY2026, down 9.3% from a year earlier and up 87.4% from the prior quarter. Over 3 fiscal years it compounded at +1.8% a year.

Context

  • Account payables amounted to 1.8% of total assets at the end of Q1 FY2026, down 0.2 pp from a year earlier.
  • Account payables increased in 1 of the last 3 fiscal years.

What to watch

Whether account payables keeps falling in the next quarterly balance sheet after a -9.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.07M+87.4% QoQ
Last fiscal yearDec 2025
$1.64M-24.1% YoY
Year agoMar 2025
$3.38M-9.3% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.3%——
1 year-24.1%——
3-year CAGR+1.8%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
1.64M USD
Year-over-year change
-24.1%
4-year CAGR
+28.1%

Account Payables vs competitors

How OPRX compares with its peers on the latest reported figures

  • Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -9.3% is the 7th highest of 9, against a peer median of +29.6%.
  • Account payables amounts to 1.8% of total assets for OPRX, versus a peer median of 1.7%.
OPRX Competitors
Account Payables for OPRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TBRGTruBridge, Inc.Mar 2026$22.48M USD+51.2%+40.6%5.5%
SOPHSOPHiA GENETICS S.A.Mar 2026$12.67M USD+175.0%+34.8%8.1%
RXSTRxSight, Inc.Mar 2026$7.12M USD+0.2%+26.8%2.3%
DHDefinitive Healthcare Corp.Mar 2026$6.02M USD-26.7%-3.1%1.2%
SPOKSpok Holdings, Inc.Mar 2026$4.93M USD+49.6%-12.2%2.5%
DRUGBright Minds Biosciences Inc.Mar 2026CA$3.63M CAD+558.5%+11.1%1.2%
OPRXOptimizeRx CorporationMar 2026$3.07M USD-9.3%+1.8%1.8%
NRCNational Research CorporationMar 2026$2.23M USD+9.7%+52.2%1.7%
SLPSimulations Plus, Inc.Feb 2026$803K USD-33.4%+27.8%0.5%
NAKANakamoto Inc.Mar 2026$0 USD——0.0%
Peer median (excluding OPRX) —+29.6%+27.3%1.7%

Competitors are the stored peer set for OPRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents84.68M18.21M13.85M13.38M23.37M
Short-term Investments055.93M000
Net Receivables24.8M22.16M37.29M38.21M37.75M
Inventory00000
Other Current Assets608.15K473.65K404.47K387K752K
Total Current Assets115.11M98.58M54.33M53.97M64.72M
Property, Plant & Equipment (Net)472.64K372.77K722.3K516K510K
Goodwill14.74M22.67M78.36M70.87M70.87M
Intangible Assets10.65M13.02M49.4M45.52M40.8M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets12.86K5.05K568.05K296K28K
Total Non-current Assets25.87M36.07M129.04M117.2M112.2M
Total Assets140.99M134.65M183.37M171.17M176.92M
Account Payables606.81K1.55M2.23M2.16M1.64M
Short-term Debt002M2M4.26M
Tax Payables0049K318K0
Deferred Revenue1.39M164.31K171.84K473K503K
Other Current Liabilities005.55M03.09M
Total Current Liabilities9.37M8.4M17.88M18.65M21.26M
Long-term Debt0034.23M30.82M21.42M
Deferred Tax Liabilities004.34M4.49M5.71M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities236.73K144.53K38.94M35.52M27.36M
Total Liabilities9.61M8.54M56.82M54.17M48.62M
Common Stock17.86K18.29K19.9K20K20K
Retained Earnings(35.25M)(46.69M)(64.26M)(84.37M)(79.24M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity131.38M126.11M126.55M117M128.29M
Total Debt327.71K234.43K36.82M33.19M26.1M
Net Debt(84.35M)(17.97M)22.97M19.81M2.74M

OptimizeRx Corporation

NASDAQ:OPRX

Intrinsic Alpha fair value

Locked

Current Price

$7.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.